NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹8,581 Cr | ₹6,887 Cr | ₹5,657 Cr | ₹5,109 Cr | ₹4,792 Cr |
What is the latest Total Liabilities ratio of NATCO PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹8,581 Cr |
| Mar2024 | ₹6,887 Cr |
| Mar2023 | ₹5,657 Cr |
| Mar2022 | ₹5,109 Cr |
| Mar2021 | ₹4,792 Cr |
How is Total Liabilities of NATCO PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹8,581 Cr | 24.59 | |
| Mar2024 | ₹6,887 Cr | 21.73 | |
| Mar2023 | ₹5,657 Cr | 10.73 | |
| Mar2022 | ₹5,109 Cr | 6.62 | |
| Mar2021 | ₹4,792 Cr | - | |
Compare Total Liabilities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,041.7 Cr | -5.8% | -8.5% | -33.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,905.0 Cr | -5.2% | -7.6% | -8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,357.0 Cr | -5.6% | -7.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,788.0 Cr | -0.6% | 4.8% | 25% | Stock Analytics | |
| CIPLA | ₹110,628.0 Cr | -4.5% | -9.7% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,441.5 Cr | -2.6% | -9.7% | -10.5% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -5.8% |
-8.5% |
-33.9% |
| SENSEX | -2.1% |
-3% |
6.8% |
You may also like the below Video Courses